Wedbush Securities Believes Positive FY3Q15 Results Bode Well For Medtronic

By: via Benzinga
In a report published Wednesday, Wedbush Securities analyst Tao Levy reiterated a Neutral rating and $75.00 price target on Medtronic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.